Phase 3 Study of MR-139 for Blepharitis Update Provided by Viatris
The MR-139 3001 Phase 3 trial consisted of a randomized, [...]
The MR-139 3001 Phase 3 trial consisted of a randomized, [...]
Explore the Healthcare Dispensing Systems Market growth, projected to hit [...]
Experienced surgeon to provide cross-functional guidance as company focuses on [...]
“Arienta is dedicated to expanding access to lifesaving cardiovascular imaging, [...]
Streifeneder is an international developer and supplier of orthopaedic mobility [...]
IDE approval in both countries follows strong feasibility clinical results [...]
The trial will be led by Principal Investigator, Dr. Fathi [...]
Midlife is about taking stock, paying attention, and making choices [...]
This agreement includes the first 400 cm, 0.018″ peripheral guidewire [...]
Continuous cardiac monitoring with Vivalink devices following surgical discharge may [...]